ArticleCancer science2013

Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy.

Yosuke Makuuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.